Products & Pipeline. About Coherus BioSciences, Inc. Coherus is a leading biosimilar company that develops and commercializes high-quality therapeutics for major regulated markets. The Investor Relations website contains information about Coherus BioSciences, Inc.'s business for stockholders, potential investors, and financial analysts. Biosimilars are safe, effective, and affordable alternatives to existing brand biologics that meet the same standards set by the US Food and Drug Administration (FDA) 1.They have the potential to offset the burdens of rising costs and diminishing access to care. Learn More. Coherus BioSciences, Inc. is a leading global biologics platform company focused on delivering high-quality biosimilar therapeutics that may expand patient access to life-changing medicines in regulated markets worldwide.
Coherus BioSciences is a leading biosimilar company that develops and commercializes high-quality therapeutics for major regulated markets.